New treatment of Duchenne muscular dystrophy
Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States
Sorodne novice
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
If approved by the European Commission, Duvyzat will be available for individuals with DMD aged six years and older who are able to walk.
Preberi več